This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by van Kerkhof, P. Articles by Strous, G. J. Search for Related Content PubMed PubMed Citation Articles by van Kerkhof, P. Articles by Strous, G. J.

The Ubiquitin-Proteasome Pathway Regulates the Availability of the GH Receptor

Department of Cell Biology and Institute of Biomembranes (P.v.K., G.J.S.), Experimental Cardiology Laboratory (M.S.), Interuniversity Cardiology Institute of the Netherlands (ICIN), University Medical Center Utrecht, Heidelberglaan 100, AZU-G02.525, 3584CX Utrecht, The Netherlands

Address all correspondence and requests for reprints to: Ger J. Strous, Ph.D., University Medical Center Utrecht, Department of Cell Biology, Heidelberg 100, AZU, G02.525, Utrecht 3584 CX, The Netherlands. e-mail: . strous{at}med.uu.nl

GH promotes not only longitudinal growth in children but is active throughout life in protein, fat, and carbohydrate metabolism. The multiple actions of GH start when GH binds to the cell surface-expressed GH receptor. Effectiveness of the hormone depends both on its presence in the circulation and the availability of receptors at the cell surface of target cells. In this study, we examined the role of the ubiquitin-proteasome pathway in regulating GH receptor availability. We show that receptor turnover is rapid, and almost 3-fold prolonged in the internalization-deficient mutant GH receptor (F327A). Using a monovalent GH antagonist, B2036, we could quantify the internalization of the nonactivated receptor. By comparing internalization of the receptor with shedding of the GH-binding protein, we show that in Chinese hamster lung cell lines, internalization followed by lysosomal degradation is the major pathway for receptor degradation and that the ubiquitin-proteasome pathway controls this process. Inhibition of endocytosis resulted in a 200% increase in receptor availability at the cell surface at steady state.

This article has been cited by other articles:

				G. Kenth, J. A M. Mergelas, and C. G. Goodyer Developmental changes in the human GH receptor and its signal transduction pathways J. Endocrinol., July 1, 2008; 198(1): 71 - 82. [Abstract] [Full Text] [PDF]

				P. van Kerkhof, J. Putters, and G. J. Strous The Ubiquitin Ligase SCF(betaTrCP) Regulates the Degradation of the Growth Hormone Receptor J. Biol. Chem., July 13, 2007; 282(28): 20475 - 20483. [Abstract] [Full Text] [PDF]

				L. Deng, K. He, X. Wang, N. Yang, C. Thangavel, J. Jiang, S. Y. Fuchs, and S. J. Frank Determinants of Growth Hormone Receptor Down-Regulation Mol. Endocrinol., July 1, 2007; 21(7): 1537 - 1551. [Abstract] [Full Text] [PDF]

				M. J. M. van den Eijnden, L. L. Lahaye, and G. J. Strous Disulfide bonds determine growth hormone receptor folding, dimerisation and ligand binding J. Cell Sci., August 1, 2006; 119(15): 3078 - 3086. [Abstract] [Full Text] [PDF]

				A. N. Bullock, J. E. Debreczeni, A. M. Edwards, M. Sundstrom, and S. Knapp Crystal structure of the SOCS2-elongin C-elongin B complex defines a prototypical SOCS box ubiquitin ligase PNAS, May 16, 2006; 103(20): 7637 - 7642. [Abstract] [Full Text] [PDF]

				M J Waters, H N Hoang, D P Fairlie, R A Pelekanos, and R J Brown New insights into growth hormone action J. Mol. Endocrinol., February 1, 2006; 36(1): 1 - 7. [Abstract] [Full Text] [PDF]

				T. Landsman and D. J. Waxman Role of the Cytokine-induced SH2 Domain-containing Protein CIS in Growth Hormone Receptor Internalization J. Biol. Chem., November 11, 2005; 280(45): 37471 - 37480. [Abstract] [Full Text] [PDF]

				K. He, K. Loesch, J. W. Cowan, X. Li, L. Deng, X. Wang, J. Jiang, and S. J. Frank Janus Kinase 2 Enhances the Stability of the Mature Growth Hormone Receptor Endocrinology, November 1, 2005; 146(11): 4755 - 4765. [Abstract] [Full Text] [PDF]

				J. W. Cowan, X. Wang, R. Guan, K. He, J. Jiang, G. Baumann, R. A. Black, M. S. Wolfe, and S. J. Frank Growth Hormone Receptor Is a Target for Presenilin-dependent {gamma}-Secretase Cleavage J. Biol. Chem., May 13, 2005; 280(19): 19331 - 19342. [Abstract] [Full Text] [PDF]

				H. Zhou, W. K. W. Ko, W. K. K. Ho, S. S. Stojilkovic, and A. O. L. Wong Novel Aspects of Growth Hormone (GH) Autoregulation: GH-Induced GH Gene Expression in Grass Carp Pituitary Cells through Autocrine/Paracrine Mechanisms Endocrinology, October 1, 2004; 145(10): 4615 - 4628. [Abstract] [Full Text] [PDF]

				J. Gent, M. van den Eijnden, P. van Kerkhof, and G. J. Strous Dimerization and Signal Transduction of the Growth Hormone Receptor Mol. Endocrinol., May 1, 2003; 17(5): 967 - 975. [Abstract] [Full Text] [PDF]

				X. Wang, K. He, M. Gerhart, Y. Huang, J. Jiang, R. J. Paxton, S. Yang, C. Lu, R. K. Menon, R. A. Black, et al. Metalloprotease-mediated GH Receptor Proteolysis and GHBP Shedding. DETERMINATION OF EXTRACELLULAR DOMAIN STEM REGION CLEAVAGE SITE J. Biol. Chem., December 20, 2002; 277(52): 50510 - 50519. [Abstract] [Full Text] [PDF]

				J. Gent, P. van Kerkhof, M. Roza, G. Bu, and G. J. Strous Ligand-independent growth hormone receptor dimerization occurs in the endoplasmic reticulum and is required for ubiquitin system-dependent endocytosis PNAS, July 23, 2002; 99(15): 9858 - 9863. [Abstract] [Full Text] [PDF]